Page 2 - U11248 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from U11248. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In U11248 Today - Breaking & Trending Today

How Does Rituximab for Pemphigus Fare in the Long Term?

This marks the first long-term follow-up data from patients in the Ritux 3 trial who received rituximab as a first-line agent. ....

Haute Normandie , Billal Tedbirt , Department Of Dermatology , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Monoclonal Antibody ,

Oncologists Sound the Alarm About Rise of White Bagging

More states are barring the practice of white bagging, while oncology groups and insurance advocates continue to debate its impacts on costs. ....

United States , Mountain View , Siteman Cancer Center , Washington University , Lemrey Al Carter , David Allen , Ted Okon , Los Angeles , Adamj Fein , Debra Patt , John Dipersio , Kathyw Oubre , Ya Chen Tina Shih , America Health Insurance Plans , Drug Administration , Drug Channels Institute , Coalition Of Hematology , American Society Of Health , American Hospital Association , Texas Society Of Clinical Oncology , Institute For Clinical , Pontchartrain Cancer Center , Association Of Community Cancer Centers , Community Oncology Alliance , National Association Of Boards Pharmacy , Washington University In St ,

The Latest Findings on Major Breast Cancer Trials

Here's a roundup of the most recent data from five phase 3 trials presented at SABCS 2023. ....

United States , San Francisco , Jo Chien , Gabriel Hortobagyi , University Of California , Md Anderson Cancer Center , University Of Frankfurt , Antonio Breast Cancer Symposium , Medical News , Cancer Center , Sibylle Loibl , Breast Cancer , Alignant Breast Neoplasm , Breast Carcinoma , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Her2 Positive Breast Cancer , Her2 Breast Cancer , Advanced Breast Cancer , Metastatic Breast Carcinoma , Metastatic Breast Cancer , Dvanced Bc , Etastatic Bc ,

When's Best to Re-dose Rituximab After Vasculitis Remission?

A single-center study found that using B-cell levels to determine when to infuse rituximab reduced relapses in patients antineutrophil cytoplasmic antibody vasculitis. ....

United States , Johnl Niles , Robert Hylland , Glomerulonephritis Center At Massachusetts , Harvard Medical School , Michigan State University College Of Osteopathic Medicine , Glomerulonephritis Center , Massachusetts General Hospital , Medscape Medical , Michigan State University College , Osteopathic Medicine , Biologic Therapy , Antineoplastic Drug , Nti Cancer Agents , Monoclonal Antibody , Covid 19 , 019 Novel Coronavirus , 019 Ncov , Uhan Coronavirus , Uman Coronavirus Hku1 , Uman Coronavirus Oc43 , Cov Oc43 , Uman Coronavirus 229e , Cov 229e ,

Mantle Cell Lymphoma: Drug Combo Improves PFS

'In the countries where ibrutinib is indicated, this combination should be a new standard therapy for relapsed/refractory mantle cell lymphoma.' ....

United States , Briant Hill , Michael Wang , Acerta Pharma , Drug Administration , American Society Of Hematology , University Of Texas Md Anderson Cancer Center , Cancer Center , American Society , Cleveland Clinic , Juno Therapeutics , Kite Pharma , Loxo Oncology , Molecular Templates , Mantle Cell Lymphoma , Non Hodgkin Amp 039s Lymphoma , Non Hodgkin Lymphoma , Malignant Lymphoma , Tyrosine Kinase Inhibitor , Biologic Therapy , Alignant Neoplasia , Alignant Neoplasm ,